Salvatore, Lisa
 Distribuzione geografica
Continente #
NA - Nord America 1.008
EU - Europa 516
AS - Asia 334
SA - Sud America 35
AF - Africa 9
Totale 1.902
Nazione #
US - Stati Uniti d'America 998
SG - Singapore 152
IT - Italia 130
SE - Svezia 101
DE - Germania 65
IN - India 62
CN - Cina 51
FR - Francia 49
FI - Finlandia 37
IE - Irlanda 37
BR - Brasile 34
AT - Austria 26
ID - Indonesia 25
GB - Regno Unito 24
HK - Hong Kong 16
RU - Federazione Russa 11
CA - Canada 8
CZ - Repubblica Ceca 8
CI - Costa d'Avorio 6
IR - Iran 6
BE - Belgio 5
ES - Italia 4
NL - Olanda 4
RO - Romania 4
CH - Svizzera 3
JP - Giappone 3
LT - Lituania 3
PK - Pakistan 3
TH - Thailandia 3
IQ - Iraq 2
SA - Arabia Saudita 2
TR - Turchia 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.902
Città #
Ashburn 506
Chandler 152
Singapore 102
Hyderabad 57
Rome 38
Dublin 37
Helsinki 34
The Dalles 27
Jakarta 25
New York 23
Vienna 22
Los Angeles 19
Boston 17
Marseille 17
Milan 17
Hong Kong 16
Princeton 15
Munich 14
Beijing 10
Cattolica 10
London 10
Chicago 9
Lauterbourg 9
Nuremberg 9
Bremen 8
Falkenstein 8
Moscow 8
Portsmouth 7
San Mateo 7
Toronto 7
Wilmington 7
Abidjan 6
Columbus 6
Düsseldorf 6
Washington 6
Bari 5
Frankfurt am Main 5
Redmond 5
Brdo 4
Brussels 4
Council Bluffs 4
Kish 4
Amsterdam 3
Boardman 3
Hounslow 3
Islamabad 3
Lappeenranta 3
Palermo 3
Piacenza 3
Pune 3
Rocca Massima 3
São Paulo 3
Timisoara 3
Tokyo 3
Arezzo 2
Bangkok 2
Barcelona 2
Bologna 2
Brasília 2
Brno 2
Buffalo 2
Cesano Maderno 2
Florence 2
Genoa 2
Guangzhou 2
Legnano 2
Lusciano 2
Markgröningen 2
Mathura 2
Menlo Park 2
Phoenix 2
Phoenixville 2
Riyadh 2
Romainville 2
Santa Clara 2
Seattle 2
Acton 1
Almaty 1
Amaseno 1
Andover 1
Anyang 1
Ardabil 1
Arujá 1
Ashgabat 1
Atlanta 1
Augusta 1
Baghdad 1
Baku 1
Bern 1
Bertioga 1
Bexley 1
Bratislava 1
Brooklyn 1
Buenos Aires 1
Cabo Frio 1
Cachoeira 1
Cambridge 1
Carapicuíba 1
Centurion 1
Comiso 1
Totale 1.406
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 521
Management of single pulmonary metastases from colorectal cancer: State of the art 88
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 87
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 86
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 85
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 75
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 72
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 67
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 66
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 66
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 57
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 54
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 53
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 51
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 50
Management of patients with early-stage colon cancer: Guidelines of the Italian Medical Oncology Association 43
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 39
PTEN in colorectal cancer: Shedding light on its role as predictor and target 39
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 38
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 36
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience 36
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 35
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 33
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation 33
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 31
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C 28
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 25
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab with or Without Atezolizumab for Patients with Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study 13
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience 12
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 11
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 9
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: Lessons from the AtezoT RIBE study 9
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 4
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 2
Totale 1.954
Categoria #
all - tutte 9.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 3 0
2020/202110 0 0 0 0 0 0 0 0 0 5 5 0
2021/2022128 7 2 0 12 3 3 2 16 4 11 35 33
2022/2023443 40 45 36 70 37 52 28 29 42 16 18 30
2023/2024778 11 50 28 24 17 42 245 258 4 18 42 39
2024/2025585 12 11 57 33 54 41 73 37 107 124 36 0
Totale 1.954